177 related articles for article (PubMed ID: 27965168)
1. A specific spectral signature of serum and plasma-derived extracellular vesicles for cancer screening.
Krafft C; Wilhelm K; Eremin A; Nestel S; von Bubnoff N; Schultze-Seemann W; Popp J; Nazarenko I
Nanomedicine; 2017 Apr; 13(3):835-841. PubMed ID: 27965168
[TBL] [Abstract][Full Text] [Related]
2. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.
Minciacchi VR; Freeman MR; Di Vizio D
Semin Cell Dev Biol; 2015 Apr; 40():41-51. PubMed ID: 25721812
[TBL] [Abstract][Full Text] [Related]
4. Label-Free Prostate Cancer Detection by Characterization of Extracellular Vesicles Using Raman Spectroscopy.
Lee W; Nanou A; Rikkert L; Coumans FAW; Otto C; Terstappen LWMM; Offerhaus HL
Anal Chem; 2018 Oct; 90(19):11290-11296. PubMed ID: 30157378
[TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study.
Shao X; Pan J; Wang Y; Zhu Y; Xu F; Shangguan X; Dong B; Sha J; Chen N; Chen Z; Wang T; Liu S; Xue W
Nanomedicine; 2017 Apr; 13(3):1051-1059. PubMed ID: 27979746
[TBL] [Abstract][Full Text] [Related]
7. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling in tissues and urine of patients with prostatic lesions and the diagnostic value of urine extracellular vesicles metabolites in prostate cancer.
Ding T; He W; Yan H; Wei Z; Zeng X; Hao X
Clin Chim Acta; 2024 Mar; 556():117845. PubMed ID: 38403146
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
[TBL] [Abstract][Full Text] [Related]
10. Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples.
Brett SI; Lucien F; Guo C; Williams KC; Kim Y; Durfee PN; Brinker CJ; Chin JI; Yang J; Leong HS
Prostate; 2017 May; 77(13):1335-1343. PubMed ID: 28762517
[TBL] [Abstract][Full Text] [Related]
11. [Representation analysis of miRNA from clarified urine and urine microvesicles in prostate malignancies and non-malignant neoplasms].
Zaporozhchenko IA; Bryzgunova OE; Lekchnov EA; Osipov ID; Zaripov MM; Yurchenko YB; Yarmoschuk SV; Pashkovskaya OA; Rykova EY; Zheravin AA; Laktionov PP
Biomed Khim; 2018 Jan; 64(1):38-45. PubMed ID: 29460833
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
Puhka M; Takatalo M; Nordberg ME; Valkonen S; Nandania J; Aatonen M; Yliperttula M; Laitinen S; Velagapudi V; Mirtti T; Kallioniemi O; Rannikko A; Siljander PR; Af Hällström TM
Theranostics; 2017; 7(16):3824-3841. PubMed ID: 29109780
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743
[TBL] [Abstract][Full Text] [Related]
14. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Xu R; Greening DW; Rai A; Ji H; Simpson RJ
Methods; 2015 Oct; 87():11-25. PubMed ID: 25890246
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A review.
Ahmadzada T; Kao S; Reid G; Clarke S; Grau GE; Hosseini-Beheshti E
Crit Rev Oncol Hematol; 2020 Jun; 150():102949. PubMed ID: 32330840
[TBL] [Abstract][Full Text] [Related]
16. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles.
Minciacchi VR; You S; Spinelli C; Morley S; Zandian M; Aspuria PJ; Cavallini L; Ciardiello C; Reis Sobreiro M; Morello M; Kharmate G; Jang SC; Kim DK; Hosseini-Beheshti E; Tomlinson Guns E; Gleave M; Gho YS; Mathivanan S; Yang W; Freeman MR; Di Vizio D
Oncotarget; 2015 May; 6(13):11327-41. PubMed ID: 25857301
[TBL] [Abstract][Full Text] [Related]
17. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of zone-specific spectral signatures in normal human prostate using Raman spectroscopy.
Patel II; Martin FL
Analyst; 2010 Dec; 135(12):3060-9. PubMed ID: 20949203
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.
Soekmadji C; Corcoran NM; Oleinikova I; Jovanovic L; ; Ramm GA; Nelson CC; Jenster G; Russell PJ
Prostate; 2017 Oct; 77(14):1416-1423. PubMed ID: 28856701
[TBL] [Abstract][Full Text] [Related]
20. [Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate].
Grond A
Versicherungsmedizin; 1995 Apr; 47(2):66-7. PubMed ID: 7539193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
